Archive: September 2021

Extra bolagstämma i Micropos Medical

Kallelse till extra bolagsstämma i Micropos Medical AB (publ) Aktieägarna i Micropos Medical AB (publ) (”Bolaget”), 556648-2310, kallas härmed till extra bolagsstämma tisdag den 12…

Read more

Clinical data from RayPilot® System use

We are very pleased to see these preliminary data from the use of the RayPilot® System for SBRT for prostate cancer patients, published in the…

Read more

FDA approval for RayPilot HypoCath

Micropos Medical has been approved by the FDA for its 510k application for the sale and marketing of RayPilot with HypoCath in the United States.…

Read more